The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people around the world suffer from long COVID-19.

When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung disease ...

Engineered stone fabrication releases toxic silica dust that can cause incurable silicosis, highlighting a growing ...

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of ...

LUBBOCK, Texas. - A Texas doctor is noticing a pattern in her patients that could reveal another possible devastating side effect of COVID-19: severely scarred lungs. Dr. Brittany Bankhead-Kendall, a ...

Existing arthritis drugs could help stop lingering lung problems that can last up to years after COVID-19 infections, according to a study from researchers at Charlottesville, Va.-based UVA Health and ...

Lung cancer is often associated with cigarette smoking, but various other factors can contribute to the development of this disease. Understanding these factors is crucial for prevention and early ...

A US teenager was recently reported to have developed the oddly named medical condition "popcorn lung" after vaping in secret for three years. Officially known as bronchiolitis obliterans, popcorn ...

What Is Jascayd, and Why Does It Matter? Jascayd (nerandomilast) is a new oral medicine approved to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is a rare and serious condition that causes ...

Pulmonary sarcoidosis is a condition that causes tiny groups of immune cells to clump in your lungs. These groups of cells form swollen, inflamed lumps called granulomas. Granulomas can make it hard ...